GENENTECH INC (NYSE:DNA)

Headlines for GENENTECH INC

Bevacizumab-Erlotinib Combination May Improve Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients
MediNEWS.Direct! - 1 hour ago
Combination treatment with bevacizumab ( AVASTIN ~® | Genentech , Inc . ) and erlotinib ( Tarceva ~® | OSI Pharmaceuticals , Inc . , Genentech , Inc . ) increases the progression - free survival ...
Genentech Disputes New Avastin Research Data
That Happened! - Nov 20, 2008
New York - According to a study published by a university research team in the Journal of the American Medical Association , Genentech ' s cancer drug Avastin significantly ups the risk of blood ...
Genentech Defends Safety Issues With Avastin Drug
SmartAboutHealth - Nov 20, 2008
Washington ( SmartAboutHealth ) - Genentech has come ou t to defend their popular cancer Avastin after it was linked to the development of blood clots in the veins.Researchers this week led by ...
Genentech Comes To Defense Of Cancer Drug Avastin
dBTechno - Nov 20, 2008
Washington ( dbTechno ) - Genentech has come to the defense of its highly - popular cancer drug Avastin.The company immediately responded to a new report released by a team of researchers which ...
Avastin More Likely to Cause Blood Clots in Veins, Study Says
Newsinferno.com - Nov 19, 2008
Avastin , Genentech ' s popular cancer drug , has been linked to an increased risk of blood clots in the veins by a new study.According to an article published in the Journal American Medical ...